COVID-19 Upended the Patient-Doctor Relationship — For the Better. What Do Consumers Living with Chronic Conditions Want Now? Registration

Date:6/23/2021

Time:1:00 PM EDT

Duration:30 minutes

Some positive changes in chronic disease care have emerged from the pandemic — improvements that patients want to carry forward, just as providers and payers are beginning to retreat to pre-pandemic norms. Consumers facing chronic conditions are actively working to reclaim their health and re-thinking the relationships and resources that will help them do that. This is a seize-the-day moment for players across the health ecosystem to embrace new approaches to patient engagement in chronic condition care, and it requires meeting people where they are and listening to understand their priorities and preferences. Join us for an interactive discussion about the new rules for patient engagement, with a focus on health social networks, and learn what's working today for innovative marketers.

If you're already registered for the "COVID-19 Upended the Patient-Doctor Relationship — For the Better. What Do Consumers Living with Chronic Conditions Want Now?" webcast, click below:

ALREADY REGISTERED?

Speakers

Eric Peacock

Cofounder and CEO

MyHealthTeams

Eric Peacock, cofounder and CEO of MyHealthTeams, is passionate about empowering people facing chronic conditions. MyHealthTeams is the largest and fastest-growing set of patient social networks in the world. Millions of diagnosed patients now rely on MyHealthTeams’ 41 condition-specific social networks for conversation with peers, practical advice, objective educational information, guidance on talking with doctors and emotional support. Recognized for leading innovation in patient education and activation, Eric is often quoted in health industry publications, was honored as a DTC Innovator in 2019 and was named to PM360’s ELITE list in 2018. He has spoken at conferences such as SXSW, Cannes Lions Health, BIO, DIA, SCOPE and Digital Pharma. Eric previously worked closely with patient communities in his role at Perlegen Sciences, focused on understanding the genetic underpinnings of chronic conditions. He is a graduate of Stanford Business School and Harvard College.